awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33838584-2C91EA27-D840-4B67-ACBD-F19DE663BBB3
Q33838584-2C91EA27-D840-4B67-ACBD-F19DE663BBB3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33838584-2C91EA27-D840-4B67-ACBD-F19DE663BBB3
Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation.
P2860
Q33838584-2C91EA27-D840-4B67-ACBD-F19DE663BBB3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33838584-2C91EA27-D840-4B67-ACBD-F19DE663BBB3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
96daf2696079f7b7060eb40276e04f359cc85805
P2860
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.